< Home < Back

Eris Lifesciences - Quaterly Results

Date: 27-10-2026
The sales declined to Rs. 4822.40 millions for the September 2026 quarter as compared to Rs. 6505.00 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 1291.50  millions from Rs. 1495.70 millions ,decline by -13.65%.Operating Profit reported a sharp decline to 2023.50 millions from 3204.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 4822.40 6505.00 -25.87 9262.30 12291.40 -24.64 18217.40 16977.50 7.30
Other Income 192.40 235.90 -18.44 456.20 462.70 -1.40 983.10 355.10 176.85
PBIDT 2023.50 3204.70 -36.86 3486.30 5594.70 -37.69 7106.40 5220.60 36.12
Interest 420.60 465.00 -9.55 842.20 916.40 -8.10 1795.40 2202.40 -18.48
PBDT 1243.90 2739.70 -54.60 2285.10 4678.30 -51.16 5164.30 3018.20 71.11
Depreciation 408.80 393.00 4.02 808.60 769.00 5.15 1543.80 1817.70 -15.07
PBT 835.10 2346.70 -64.41 1476.50 3909.30 -62.23 3620.50 1200.50 201.58
TAX -456.40 851.00 -153.63 -298.00 1413.70 -121.08 1180.00 426.60 176.61
Deferred Tax -594.90 441.90 -234.62 -538.80 732.90 -173.52 570.40 206.80 175.82
PAT 1291.50 1495.70 -13.65 1774.50 2495.60 -28.89 2440.50 773.90 215.35
Equity 138.70 136.20 1.84 138.70 136.20 1.84 138.50 136.20 1.69
PBIDTM(%) 41.96 49.27 -14.83 37.64 45.52 -17.31 39.01 30.75 26.86